1-9 of 9
Stacey Dacosta Byfield
Close
Sort by
Journal Articles

Drug Therapy Treatment Regimens for Transplant Ineligible Newly Diagnosed Multiple Myeloma

Alia Rawji, Henry (Joe) Henk, Stacey Dacosta Byfield, Tejas Patel, Lucy R. Langer
Journal: Blood
Blood (2022) 140 (Supplement 1): 12581–12582.
https://doi.org/10.1182/blood-2022-170240
Published: 2022
Journal Articles

Real World Treatment Patterns, Adverse Events and Healthcare Resource Utilization and Costs Among Chronic Lymphocytic Leukemia (CLL) Patients in the United States

Shaum Kabadi, PhD MPH, Lisa Le, Stacey Dacosta Byfield, PhD MPH, Temitope O Olufade, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 837.
https://doi.org/10.1182/blood-2018-99-114731
Published: 2018
Journal Articles

What Is the Cost of Disease Progression Among Patients with Indolent or Aggressive Non-Hodgkin Lymphoma (NHL)?

Nicole Engel-Nitz, PhD, Stacey Dacosta Byfield, PhD MPH, Timothy Bancroft, PhD, Anderson J. Amy, M.S., Carolina Reyes, PhD, May Chen, MD, Matthew J. Matasar, MD MS
Journal: Blood
Blood (2016) 128 (22): 5957.
https://doi.org/10.1182/blood.V128.22.5957.5957
Published: 2016
Journal Articles

Real-World Health Care Utilization and Costs Among Patients Newly Initiating Systemic Therapy for Chronic Lymphocytic Leukemia (CLL) in the United States

Matthew J. Matasar, MD MS, Stacey Dacosta Byfield, PhD MPH, Cori Blauer-Peterson, MPH, Melissa Montez, PharmD, Carolina Reyes, PhD, Anthony Masaquel, PhD MPH
Journal: Blood
Blood (2016) 128 (22): 5928.
https://doi.org/10.1182/blood.V128.22.5928.5928
Published: 2016
Journal Articles

Differences in Patients with Progressive Versus Non-Progressive AML, CLL, or NHL: Implications for Proposed Bundled Payment Strategies

Stacey Dacosta Byfield, PhD MPH, Nicole Engel-Nitz, PhD, Timothy Bancroft, PhD, Amy J Anderson, MS, Carolina Reyes, PhD, Arliene Ravelo, MPH, Sarika Ogale, PhD, May Chen, MD, Matthew J. Matasar, MD MS
Journal: Blood
Blood (2015) 126 (23): 4528.
https://doi.org/10.1182/blood.V126.23.4528.4528
Published: 2015
Journal Articles

Differences In Treatment Patterns and Costs Among Diffuse Large B-Cell Lymphoma Patients Treated In The Clinic Vs. The Hospital Outpatient Setting

Carolina Reyes, PhD, Stacey Dacosta Byfield, Laura K. Becker, MS, Art Small, MD
Journal: Blood
Blood (2013) 122 (21): 1751.
https://doi.org/10.1182/blood.V122.21.1751.1751
Published: 2013
Journal Articles

Treatment Persistence with Azacitdine (Vidaza) Is Associated with Lower Inpatient Hospitalization Costs Over Time

B. Douglas Smith, M.D., Dalia Mahmoud, MBA, Stacey Dacosta Byfield, Henry J Henk, PhD
Journal: Blood
Blood (2012) 120 (21): 4231.
https://doi.org/10.1182/blood.V120.21.4231.4231
Published: 2012
Journal Articles

Are There Differences in Patient Characteristics, Treatment Patterns and Costs by Treatment Setting?

Stacey Dacosta Byfield, Carolina Reyes, Ph.D., Laura K Becker, MS, Art Small, MD
Journal: Blood
Blood (2012) 120 (21): 4259.
https://doi.org/10.1182/blood.V120.21.4259.4259
Published: 2012
Journal Articles

Health Care Utilization, Risk of Infection and Bleeding Among MDS Patients During Periods of Transfusion Dependency or Independency with or without Active Therapy

B. Douglas Smith, MD, Dalia Mahmoud, Stacey Dacosta Byfield, Zeba M. Khan, PhD
Journal: Blood
Blood (2011) 118 (21): 3149.
https://doi.org/10.1182/blood.V118.21.3149.3149
Published: 2011